We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+11.18%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$3.07B
AUM Growth
+$226M
Cap. Flow
-$6.05M
Cap. Flow %
-0.2%
Top 10 Hldgs %
24.71%
Holding
329
New
29
Increased
101
Reduced
173
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 25.97%
2 Technology 23.54%
3 Industrials 17.51%
4 Consumer Discretionary 11.34%
5 Communication Services 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHVN
51
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$18.1M 0.59%
+264,558
New +$21.4M
TFX icon
52
Teleflex
TFX
$5.98B
$17.3M 0.57%
41,748
-1,787
-4% -$715K
KPTI icon
53
Karyopharm Therapeutics
KPTI
$48M
$16.4M 0.54%
104,203
+703
+0.7% +$148K
GBT
54
DELISTED
Global Blood Therapeutics, Inc.
GBT
$16.3M 0.53%
399,305
+5,890
+1% +$271K
WIFI
55
DELISTED
Boingo Wireless, Inc.
WIFI
$15.8M 0.52%
1,123,251
-507,155
-31% -$6.61M
CATM
56
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$15.5M 0.51%
400,353
-456,979
-53% -$17.8M
CSOD
57
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$15M 0.49%
343,814
+503
+0.1% +$23.2K
ACAD icon
58
Acadia Pharmaceuticals
ACAD
$5.03B
$14.8M 0.48%
573,936
+299,777
+109% +$13.2M
PCOM
59
DELISTED
Points.com Inc. Common Shares
PCOM
$13.9M 0.45%
911,203
+42,698
+5% +$644K
RETA
60
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$13.4M 0.44%
134,723
-1,105
-0.8% -$129K
KNSA icon
61
Kiniksa Pharmaceuticals
KNSA
$5.93B
$12.3M 0.4%
666,353
+66,836
+11% +$1.37M
INSM icon
62
Insmed
INSM
$28.6B
$11.7M 0.38%
344,318
-17,532
-5% -$670K
ZGNX
63
DELISTED
Zogenix, Inc.
ZGNX
$11.5M 0.37%
588,251
+39,603
+7% +$812K
NKTR icon
64
Nektar Therapeutics
NKTR
$2.58B
$11.3M 0.37%
37,739
-153
-0.4% -$47.6K
LMAT icon
65
LeMaitre Vascular
LMAT
$1.86B
$11.2M 0.36%
229,506
+21,455
+10% +$1.01M
FC icon
66
Franklin Covey
FC
$246M
$11.1M 0.36%
393,896
+12,123
+3% +$317K
MIME
67
DELISTED
Mimecast Limited
MIME
$11M 0.36%
272,465
+112,086
+70% +$4.94M
CSW
68
CSW Industrials
CSW
$5.71B
$10.7M 0.35%
79,249
+25
+0% +$3.17K
CSGP icon
69
CoStar Group
CSGP
$12.3B
$10.6M 0.35%
128,770
-5,580
-4% -$482K
RXT icon
70
Rackspace Technology
RXT
$1.24B
$10.2M 0.33%
+430,083
New +$9.27M
MSM icon
71
MSC Industrial Direct
MSM
$6.86B
$10.2M 0.33%
112,692
-609
-0.5% -$51.9K
UTMD icon
72
Utah Medical Products
UTMD
$225M
$10.1M 0.33%
116,996
+12,921
+12% +$1.14M
APEI icon
73
American Public Education
APEI
$940M
$10.1M 0.33%
+284,221
New +$8.9M
AAP icon
74
Advance Auto Parts
AAP
$3.49B
$9.88M 0.32%
53,828
-2,308
-4% -$387K
ACLS icon
75
Axcelis
ACLS
$4.33B
$9.17M 0.3%
223,258
-2,798
-1% -$104K

Similar funds

Rice Hall James & Associates's Q1 2021 Portfolio in Review

As of Q1 2021, Rice Hall James & Associates held 329 positions worth $3.07B, up 7.9% from $2.84B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates's Q1 2021 filing shows 29 new, 101 increased, 173 reduced and 14 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 264,558 shares worth $18.1M. The largest sale was Etsy, an estimated $49.1M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q1 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 264,558 shares worth $18.1M.
  • Rice Hall James & Associates added most to Stride in Q1 2021, an estimated $15.5M increase.
  • Rice Hall James & Associates's biggest Q1 2021 reduction was Etsy, cutting an estimated $49.1M.
  • Rice Hall James & Associates fully exited Grand Canyon Education in Q1 2021, selling an estimated $6.68M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $3.07B portfolio in Q1 2021.
  • Rice Hall James & Associates opened 29 new positions and closed 14 in Q1 2021.
  • Rice Hall James & Associates's portfolio value rose 7.9% quarter-over-quarter to $3.07B.

Based on Rice Hall James & Associates's 13F filing for Q1 2021, filed 14 May 2021.